Remove 2011 Remove Healthcare Provider Remove Prescription Remove Sales
article thumbnail

Specialty Treatments Require a New Approach to Affordability

PM360

As a mission-driven company and digital healthcare leader, GoodRx has helped patients obtain an estimated 80 million prescriptions they otherwise may not have been able to afford. Figure 1: Share of net spending for specialty and traditional prescription medications. The Uses—and Costs—of Specialty Treatments Keep Rising A U.S.

article thumbnail

Exforge antitrust settlement caps Novartis’ year of legal disputes

Pharmaceutical Technology

This class-action litigation specifically focused on a 2011 licensing agreement between the two companies. In a press release, the company said a generic launch would damage sales in FY 2023 by $300,000. In September, Novartis announced its plans to petition the US Supreme Court to reverse the aforementioned decision.